HSPMdb Accession No | HSPMDB000581 |
PMID | 19195901 |
Target | Hsp70 |
HSP Name | PfHsp70 |
Organism | Plasmodium falciparum |
Localization | Cytosol and nucleus |
Cellular activity | Antiparasitic activity (inhibition of [3H]hypoxanthine uptake) |
Compound Name | MAL3-39 |
IUPAC Name | benzyl 1-{3-[({[1,1'-biphenyl]-4-yl}(tert-butylcarbamoyl)methyl)[2-(morpholin-4-yl)ethyl]carbamoyl]propyl}-6-methyl-4-(4-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate |
SMILES | CC1=C(C(NC(=O)N1CCCC(=O)N(CCN1CCOCC1)C(C(=O)NC(C)(C)C)C1=CC=C(C=C1)C1=CC=CC=C1)C1=CC=C(C=C1)[N+]([O-])=O)C(=O)OCC1=CC=CC=C1 |
Class | Pyrimidinone amide |
IC50 (µM) | 0.8 |
Cellular assay | [3H]hypoxanthine uptake assay |
Cellular Model | P. falciparum |
Disease | Malaria |